SCHEMBL8201465

SCHEMBL8201465

CC(c1cn(S(=O)(=O)c2ccccc2)c2ccc(OC3CCCCC3)cc12)C1CCCN1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 20/20 0.43
DRD2 P14416 1/20 0.39
HTR2A P28223 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8208098 0.92 HTR6 (0.48) HTR6HTR2A
SCHEMBL8208544 0.92 HTR6 (0.44) HTR6
SCHEMBL8201606 0.88 HTR6 (0.45) HTR6DRD2HTR2A
SCHEMBL8209777 0.85 HTR6 (0.53) HTR6DRD2HTR2A
SCHEMBL8209521 0.83 HTR6 (0.51) HTR6
SCHEMBL8200945 0.83 HTR6 (0.47) HTR6
SCHEMBL8208533 0.83 HTR6 (0.57) HTR6
SCHEMBL8213329 0.81 PTGS1 (0.38) HTR6
SCHEMBL8201576 0.80 HTR6 (0.63) HTR6
SCHEMBL8201582 0.79 HTR6 (0.50) HTR6DRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6100291-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-08 US claimed
WO-1999047516-A1 3-(2-PYRROLIDINYLMETHYL)-INDOLE COMPOUNDS HAVING 5-HT6 AFFINITY SLASSI ABDELMALIK (CA) 1999-09-23 WO claimed
US-6100291-A FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ALLELIX BIOPHARMACEUTICALS INC. (CA) 2000-08-08 US disclosed
WO-1999047516-A1 3-(2-PYRROLIDINYLMETHYL)-INDOLE COMPOUNDS HAVING 5-HT6 AFFINITY SLASSI ABDELMALIK (CA) 1999-09-23 WO disclosed